These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39008851)

  • 1. Summary for Patients: Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes.
    Ann Intern Med; 2024 Aug; 177(8):I14. PubMed ID: 39008851
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes : A Target Trial Emulation Study.
    Tang H; Lu Y; Donahoo WT; Shao H; Shi L; Fonseca VA; Guo Y; Bian J; Guo J
    Ann Intern Med; 2024 Aug; 177(8):1004-1015. PubMed ID: 39008852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS).
    McIntyre RS; Mansur RB; Rosenblat JD; Kwan ATH
    Expert Opin Drug Saf; 2024 Jan; 23(1):47-55. PubMed ID: 38087976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study.
    Yeh JG; Newsome PN
    Hepatology; 2024 Jun; 79(6):1255-1257. PubMed ID: 38345826
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary Review Finds No Link Between GLP-1 Receptor Agonists and Suicidality.
    Aschenbrenner DS
    Am J Nurs; 2024 May; 124(5):20. PubMed ID: 38661695
    [No Abstract]   [Full Text] [Related]  

  • 6. Dispensing of Glucagon-Like Peptide-1 Receptor Agonists to Adolescents and Young Adults, 2020-2023.
    Lee JM; Sharifi M; Oshman L; Griauzde DH; Chua KP
    JAMA; 2024 Jun; 331(23):2041-2043. PubMed ID: 38776113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
    Levi M
    JAMA; 2024 Jul; 332(2):171. PubMed ID: 38819978
    [No Abstract]   [Full Text] [Related]  

  • 8. Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
    Hobai IA
    JAMA; 2024 Jul; 332(2):171-172. PubMed ID: 38819980
    [No Abstract]   [Full Text] [Related]  

  • 9. Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
    Milder DA; Milder TY; Kam P
    JAMA; 2024 Jul; 332(2):170-171. PubMed ID: 38819986
    [No Abstract]   [Full Text] [Related]  

  • 10. Regional socioeconomic deprivation associated with the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes in Germany.
    Auzanneau M; Seufert J; Zimny S; Haak T; Zeyfang A; Gölz S; Hugenberg I; Pavel M; Rosenbauer J; Holl RW
    Diabetes Obes Metab; 2024 Sep; 26(9):4116-4120. PubMed ID: 38982585
    [No Abstract]   [Full Text] [Related]  

  • 11. [Not Available].
    Wachter J
    MMW Fortschr Med; 2024 Jun; 166(10):11. PubMed ID: 38806898
    [No Abstract]   [Full Text] [Related]  

  • 12. The tip of the iceberg: Will GLP-1 receptor agonists unintentionally contribute to titanic cardiovascular events in certain individuals?
    Arena R; Pronk NP; Lavie CJ
    Curr Probl Cardiol; 2024 Aug; 49(8):102676. PubMed ID: 38795802
    [No Abstract]   [Full Text] [Related]  

  • 13. First Large Study of GLP-1 Receptor Agonists During Pregnancy.
    Harris E
    JAMA; 2024 Jan; 331(4):280. PubMed ID: 38170560
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas.
    McIntyre RS
    Expert Opin Drug Saf; 2024 May; 23(5):539-542. PubMed ID: 38520274
    [No Abstract]   [Full Text] [Related]  

  • 15. Preoperative GLP-1 Receptor Agonist Use and Risk of Postoperative Respiratory Complications.
    Dixit AA; Bateman BT; Hawn MT; Odden MC; Sun EC
    JAMA; 2024 May; 331(19):1672-1673. PubMed ID: 38648036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of glucagon-like peptide 1 receptor agonists in management of obesity.
    Isaacs D; Prasad-Reddy L; Srivastava SB
    Am J Health Syst Pharm; 2016 Oct; 73(19):1493-507. PubMed ID: 27521241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists.
    Emanuel EJ; Dellgren JL; McCoy MS; Persad G
    N Engl J Med; 2024 May; 390(20):1839-1842. PubMed ID: 38630999
    [No Abstract]   [Full Text] [Related]  

  • 18. Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists.
    Foer D; Beeler PE; Cui J; Karlson EW; Bates DW; Cahill KN
    Am J Respir Crit Care Med; 2021 Apr; 203(7):831-840. PubMed ID: 33052715
    [No Abstract]   [Full Text] [Related]  

  • 19. Table: GLP-1 and GIP/GLP-1 receptor agonists for type 2 diabetes.
    Med Lett Drugs Ther; 2024 Aug; 66(1708):e1-e3. PubMed ID: 39137181
    [No Abstract]   [Full Text] [Related]  

  • 20. SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study.
    Fu EL; Wexler DJ; Cromer SJ; Bykov K; Paik JM; Patorno E
    BMJ; 2024 Jun; 385():e078483. PubMed ID: 38925801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.